We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. To compare avacopan (CCX168, ChemoCentryx) with a ...
New treatment strategies in clinical trials show promise in reducing the tapering time of glucocorticoids (GCs) or possibly even replacing the use of GCs. Selective GC receptor agonists and modulators ...
Gradual withdrawal of glucocorticoids was successful among patients with systemic lupus erythematosus (SLE) after 2 years of clinically quiescent disease, without an increased likelihood of flares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results